Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 7 of 7

Publication Record

Connections

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.
Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M, Riely GJ
(2013) Clin Cancer Res 19: 2240-7
MeSH Terms: Adenocarcinoma, Adult, Aged, Aged, 80 and over, Biopsy, CD56 Antigen, DNA Mutational Analysis, Drug Resistance, Neoplasm, ErbB Receptors, Erlotinib Hydrochloride, Female, Gefitinib, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Kaplan-Meier Estimate, Ki-67 Antigen, Lung, Lung Neoplasms, Male, Middle Aged, Mutation, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-met, Quinazolines, Receptor, ErbB-2
Added September 3, 2013
0 Communities
2 Members
0 Resources
26 MeSH Terms
P75 neurotrophin receptor regulates expression of neural cell adhesion molecule 1.
Mirnics ZK, Yan C, Portugal C, Kim TW, Saragovi HU, Sisodia SS, Mirnics K, Schor NF
(2005) Neurobiol Dis 20: 969-85
MeSH Terms: Alzheimer Disease, Animals, Animals, Newborn, Binding Sites, Brain, CD56 Antigen, Disease Models, Animal, Gene Expression Regulation, Humans, Membrane Proteins, Mice, Mice, Knockout, Mice, Transgenic, Mutation, Nerve Growth Factor, Neurons, PC12 Cells, Palmitic Acid, Presenilin-1, Protein Structure, Tertiary, Rats, Receptor, Nerve Growth Factor, Receptor, trkA, Up-Regulation
Added February 12, 2015
0 Communities
1 Members
0 Resources
24 MeSH Terms
Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.
Higano CS, Vogelzang NJ, Sosman JA, Feng A, Caron D, Small EJ
(2004) Clin Cancer Res 10: 1219-25
MeSH Terms: Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Hormonal, CD56 Antigen, Dendritic Cells, Drug Resistance, Neoplasm, Flow Cytometry, Hematopoietic Stem Cells, Humans, Leukocytes, Mononuclear, Lymphocytes, Male, Membrane Proteins, Middle Aged, Monocytes, Placebos, Prostate-Specific Antigen, Prostatic Neoplasms, Random Allocation, Recombinant Proteins, Time Factors
Added March 5, 2014
0 Communities
1 Members
0 Resources
22 MeSH Terms
A phase II trial of interleukin-2 in myelodysplastic syndromes.
Nand S, Stock W, Stiff P, Sosman J, Martone B, Radvany R
(1998) Br J Haematol 101: 205-7
MeSH Terms: Adult, Aged, Aged, 80 and over, CD56 Antigen, Female, Humans, Interleukin-2, Killer Cells, Natural, Lymphocyte Count, Male, Middle Aged, Myelodysplastic Syndromes, Receptors, IgG
Added March 5, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
A phase I trial of continuous infusion interleukin-4 (IL-4) alone and following interleukin-2 (IL-2) in cancer patients.
Sosman JA, Fisher SG, Kefer C, Fisher RI, Ellis TM
(1994) Ann Oncol 5: 447-52
MeSH Terms: Adult, Aged, Antigens, CD, Antigens, Differentiation, T-Lymphocyte, CD56 Antigen, Drug Administration Schedule, Edema, Eosinophilia, Eosinophils, Female, Humans, Infusions, Intravenous, Interleukin-2, Interleukin-4, Killer Cells, Lymphokine-Activated, Killer Cells, Natural, Leukocyte Count, Male, Middle Aged, Neoplasms
Added March 5, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
Weil-Hillman G, Fisch P, Prieve AF, Sosman JA, Hank JA, Sondel PM
(1989) Cancer Res 49: 3680-8
MeSH Terms: Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, CD2 Antigens, CD56 Antigen, Cell Separation, Cytotoxicity, Immunologic, Flow Cytometry, Humans, Immunity, Cellular, In Vitro Techniques, Interleukin-2, Killer Cells, Natural, Lymphocyte Activation, Lymphocytes, Receptors, Fc, Receptors, IgG, Receptors, Immunologic, Recombinant Proteins
Added March 5, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM
(1990) Cancer Res 50: 2683-91
MeSH Terms: Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, CD3 Complex, CD56 Antigen, Dose-Response Relationship, Drug, Humans, Interleukin-2, Killer Cells, Lymphokine-Activated, Lymphocyte Activation, Phenotype, Receptors, Antigen, T-Cell, Receptors, Interleukin-2
Added March 5, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms